SnagRx vs Embody: Compare $69 Semaglutide Plans and Terms
SnagRx vs Embody: both advertise compounded semaglutide from $69/month and tirzepatide from $119/month, but the two services differ on pricing commitments, price guarantees, clinician and pharmacy disclosures, and customer guarantees. Early verdict: choose SnagRx if you want a locked-in rate across titration and named partner pharmacies; choose Embody if you want $69 without a 12-month commitment.
Quick direct comparison: what differs most
This comparison focuses on four distinctive differences supported by the source material: pricing structure and commitment, price lock and re-pricing risk, transparency about clinician network and pharmacies, and guarantees plus support features. Both providers ship in 1 to 2 days and offer compounded semaglutide and tirzepatide at similar entry prices, but the qualifiers below explain how they are not identical offers.
1. Pricing structure and commitment
SnagRx lists semaglutide from $69/month and tirzepatide from $119/month on a 12-month plan. The source states the advertised $69 and $119 figures require the 12-month plan; month-to-month pricing is $99 and $149. Embody lists semaglutide at $69/month and tirzepatide at $119/month with no long-term commitment and an explicit cancel anytime policy. In short, both show the same headline price, but SnagRx ties that price to a 12-month plan while Embody advertises $69 as a no-commitment price.
2. Price lock versus limited-time pricing
SnagRx advertises that its rate is locked flat at every dose and at renewal, explicitly noting that the rate does not rise as dose escalates. The source highlights that many compounded programs re-price during titration and positions SnagRx as charging one rate per medication for the duration. Embody states flat locked in monthly pricing and also notes the $69 offer was reduced from $299, with a source statement that the $69 price is a limited-time offer that may increase. The practical difference is that SnagRx emphasizes an ongoing price lock across titration for customers on the annual plan, while Embody frames $69 as a current low entry price that may change.
3. Transparency about clinicians and pharmacies
SnagRx names its four US 503A partner pharmacies and its clinician network, OpenLoop Health, and states OpenLoop clinicians cover 48 states. The source says SnagRx states LegitScript certification and that clinicians typically review intake within five hours. Embody is described as a licensed telehealth platform with medication filled at a licensed pharmacy, but the captured source does not name individual partner pharmacies or an equivalent clinician network by name. Use this difference if pharmacy naming and named clinician networks matter to you.
Check SnagRx clinician and pharmacy details
4. Guarantees and support
SnagRx lists a full refund if a prescription is declined and a 6-month weight-loss guarantee with terms that apply. The source also notes clinician review timelines and next-day temperature-controlled shipping. Embody highlights free 1 to 2 day shipping and states 24/7 support access for dosing and side-effect questions. Embody emphasizes a lean, no-frills model and fast delivery. The distinction: SnagRx advertises outcome guarantees and refund terms explicitly, while Embody emphasizes continuous support access and no long-term commitment.
Side-by-side at a glance
| Criterion | SnagRx | Embody |
|---|---|---|
| Entry semaglutide price | From $69/month on 12-month plan | $69/month with no long-term commitment |
| Tirzepatide price | $119/month on 12-month plan | $119/month |
| Price lock | Rate locked flat at every dose and at renewal on annual plan | Flat monthly pricing advertised; $69 described as a limited-time offer |
| Clinician and pharmacy transparency | Names OpenLoop Health clinician network and four US 503A partner pharmacies | Licensed provider review and pharmacy fill; partner names not specified in source |
| Guarantees and support | Full refund if prescription declined; 6-month weight-loss guarantee terms apply | 24/7 support access for dosing and side-effect questions; cancel anytime |
| Shipping | Next-day UPS or FedEx; temperature-controlled packaging | Free shipping; delivered in 1 to 2 days after approval |
How to pick between SnagRx and Embody
Decide which of the documented differences matters most. If a locked-in rate across dose titration and named partner pharmacies and clinician network are priorities, SnagRx documents those specifics and ties the $69 and $119 figures to a 12-month plan. If you prefer a no-commitment $69 entry price with fast delivery and 24/7 support access, Embody presents $69 as a current no-commitment price with free 1 to 2 day shipping.
Compare SnagRx annual plan details
Conclusion: SnagRx vs Embody
In direct comparison, SnagRx vs Embody share the same headline entry prices for compounded semaglutide and tirzepatide, but they differ on commitment, price guarantees, named partnerships, and stated guarantees. Use SnagRx if you want price certainty across titration and named pharmacy partnerships. Use Embody if you want the $69 entry price without a 12-month commitment and you value around-the-clock support.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
